The Na+/I symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate

  1. Orsolya Dohán*,,
  2. Carla Portulano*,
  3. Cécile Basquin*,
  4. Andrea Reyna-Neyra,
  5. L. Mario Amzel§, and
  6. Nancy Carrasco*,
  1. Departments of *Molecular Pharmacology and
  2. Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461; and
  3. §Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205
  1. Edited by H. Ronald Kaback, University of California, Los Angeles, CA, and approved October 30, 2007 (received for review July 31, 2007)

Abstract

The Na+/I symporter (NIS) is a key plasma membrane protein that mediates active I uptake in the thyroid, lactating breast, and other tissues with an electrogenic stoichiometry of 2 Na+ per I. In the thyroid, NIS-mediated I uptake is the first step in the biosynthesis of the iodine-containing thyroid hormones, which are essential early in life for proper CNS development. In the lactating breast, NIS mediates the translocation of I to the milk, thus supplying this essential anion to the nursing newborn. Perchlorate (ClO4 ) is a well known competitive inhibitor of NIS. Exposure to food and water contaminated with ClO4 is common in the U.S. population, and the public health impact of such exposure is currently being debated. To date, it is still uncertain whether ClO4 is a NIS blocker or a transported substrate of NIS. Here we show in vitro and in vivo that NIS actively transports ClO4 , including ClO4 translocation to the milk. A simple mathematical fluxes model accurately predicts the effect of ClO4 transport on the rate and extent of I accumulation. Strikingly, the Na+/ ClO4 transport stoichiometry is electroneutral, uncovering that NIS translocates different substrates with different stoichiometries. That NIS actively concentrates ClO4 in maternal milk suggests that exposure of newborns to high levels of ClO4 may pose a greater health risk than previously acknowledged because ClO4 would thus directly inhibit the newborns' thyroidal I uptake.

Footnotes

  • To whom correspondence should be addressed. E-mail: carrasco{at}aecom.yu.edu
  • Author contributions: O.D. and C.P. contributed equally to this work; O.D., C.P., C.B., A.R.-N., L.M.A., and N.C. designed research; O.D., C.P., C.B., A.R.-N., L.M.A., and N.C. performed research; O.D., C.P., C.B., L.M.A., and N.C. analyzed data; and O.D., C.P., C.B., L.M.A., and N.C. wrote the paper.

  • Present address: National Institute of Oncology and Institute of Experimental Medicine, Hungarian Academy of Sciences, Rath Gyorgy u. 7–9, 1122 Budapest, Hungary.

  • The authors declare no conflict of interest.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at www.pnas.org/cgi/content/full/0707207104/DC1.

  • Freely available online through the PNAS open access option.

« Previous | Next Article »Table of Contents
OPEN ACCESS ARTICLE